• The Daily Hints
• 03 Oct, 2025

§  Rajasthan Child Deaths

§  Toxic Cough Syrup Kills 9 Children

§  Major Investigation Launched Across India

§  Government Medicine Recall After Toxic Syrup Tragedy

§  Contaminated Cough Syrup Linked to Multiple Child Deaths in India

A devastating health crisis has emerged across two Indian states as toxic cough syrup distributed through government healthcare systems has been linked to multiple child deaths, triggering nationwide concerns about medicine safety and quality control. The tragedy has claimed at least nine children’s lives and left dozens more hospitalized, exposing critical gaps in India’s pharmaceutical oversight system.

Immediate Crisis Unfolds

The crisis began when a five-year-old boy in Sikar district died within hours of consuming government-supplied cough syrup on September 28th. The child developed severe hiccups at 3 AM after taking the medicine and was found unresponsive by morning, despite being rushed to multiple hospitals. This incident quickly escalated when authorities discovered similar patterns across both Rajasthan and Madhya Pradesh.

Kayson Pharma, a Jaipur-based pharmaceutical company, manufactured the controversial syrup containing dextromethorphan hydrobromide. The medicine was distributed through Rajasthan’s free healthcare scheme, reaching over 1.33 lakh patients since July 2025.

Shocking Medical Demonstration Goes Wrong

In a dramatic attempt to prove the syrup’s safety, Dr. Tarachand Yogi, head of Bayana Community Health Centre, consumed the medication in front of worried families on September 24th. Eight hours later, he was found unconscious in his car, requiring immediate hospitalization. Two ambulance workers who also consumed the syrup experienced similar adverse reactions, though they recovered.

“The patient came to me on September 23 with bronchitis. We prescribed the cough syrup within the prescribed dose of 1.5 ml. But when the patient came back, he was drowsy,” the treating doctor explained.

Multi-State Investigation Reveals Systemic Issues

The National Centre for Disease Control (NCDC) has deployed investigative teams to both affected states, collecting water, drug and entomological samples for comprehensive testing. Initial findings suggest diethylene glycol contamination - the same toxic chemical linked to previous international incidents involving Indian-made medicines.

·       Madhya Pradesh’s Chhindwara Crisis

o   Nine children dead from kidney failure in 15 days

o   Victims had consumed Coldrif and Nextro-DS syrups

o   Kidney biopsies revealed diethylene glycol presence

o   1,420 children under active monitoring

·       Rajasthan's Healthcare Emergency

o   22 batches banned immediately

o   Over 8,200 bottles recalled from SMS Hospital Jaipur

o   Two healthcare workers dismissed for improper prescribing

Government Response and Accountability Measures

Rajasthan Health Minister Gajendra Singh Khinsar ordered immediate investigations and formed a three-member inquiry committee. The Rajasthan Medical Services Corporation Limited (RMSCL) has halted all supplies and distribution of the controversial medicine.

·       Key Actions Taken

o   Complete ban on dextromethorphan hydrobromide syrups statewide

o   Suspension of doctor and pharmacist in Sikar district

o   Formation of emergency monitoring protocols

o   Advisory issued to all healthcare providers

However, government investigations claim that in several cases, the medicine was administered at home without proper medical supervision, potentially complicating the direct causation links.

Historical Context of Medicine Safety Crisis

This incident echoes previous international scandals involving Indian-manufactured medicines. In 2022, India-made cough syrups were linked to 141 children’s deaths in Gambia, Uzbekistan and Cameroon due to similar toxic contamination. The recurring pattern highlights persistent quality control challenges in India's $42 billion pharmaceutical industry.

·       Previous International Cases

o   Gambia: Over 70 child deaths from Maiden Pharma products

o   Uzbekistan: 18 deaths linked to contaminated syrups

o   Cameroon: Multiple fatalities from toxic medicines

Medical Expert Analysis and Safety Protocols

Healthcare professionals emphasize that dextromethorphan-based syrups should never be administered to children under five years. The tragedy has exposed widespread protocol violations in government healthcare facilities.

“Parents should not administer any syrup or medication without a doctor’s prescription, especially for children under five,” advised a Jaipur-based pulmonologist.

·       Critical Safety Violations Identified

o   Inappropriate age-group prescriptions

o   Lack of proper dosage guidelines

o   Insufficient quality testing protocols

o   Inadequate storage and handling procedures

Pharmaceutical Industry Under Scrutiny

The crisis has reignited debates about India’s pharmaceutical manufacturing standards and export regulations. Drug Controller Ajay Phatak confirmed that samples from affected batches are undergoing comprehensive testing, with results expected within days.

Industry insiders reveal that contamination typically occurs when industrial-grade chemicals infiltrate pharmaceutical supply chains instead of medical-grade solvents. Many state drug administrations lack adequate testing facilities to detect such adulteration.

Read More: West Bengal Braces For Severe Weather Alert As Deep Depression Brings Torrential Rainfall

Public Health Impact and Social Media Response

The tragedy has sparked widespread public outrage and calls for stronger pharmaceutical oversight. Social media campaigns using hashtags like #oughSyrupDeaths and #ildSafety have gained significant traction, demanding accountability from both manufacturers and government agencies.youtube

·       Community Impact

o   Families afraid to use government-supplied medicines

o   Increased demand for private healthcare consultations

o   Public trust in free medicine schemes severely damaged

o   Calls for transparent pharmaceutical supply chain tracking

Ongoing Investigation and Future Implications

As investigations continue, authorities are examining whether other states may have received contaminated batches through similar procurement processes. The Central Drugs Standard Control Organisation (CDSCO) is conducting nationwide reviews of pharmaceutical manufacturing facilities and quality control systems.

·       Expected Outcomes

o   Comprehensive audit of all government medicine suppliers

o   Stricter quality testing protocols implementation

o   Enhanced pediatric medicine safety guidelines

Potential criminal charges against negligent parties

This devastating incident serves as a wake-up call for India's healthcare system, highlighting the urgent need for robust pharmaceutical oversight, especially for medicines intended for vulnerable populations like children. The tragedy underscores that healthcare safety cannot be compromised, regardless of cost considerations or administrative conveniences.

Follow and share The Daily Hints for latest updates on healthcare safety and pharmaceutical investigations.

Follow The Daily Hints on Social Media,

      §  Facebook

      §  Instagram

      §  Threads

      §  WhatsApp

      §  YouTube

      §  Twitter

      §  Email ID

From West Bengal District’s News to Kolkata News, Other States News to Whole India News, International News, Entertainment News to Sports News, Science News to Technology News and all other news updates, follow and Support our news portal @TheDailyHints.